Two-day symposium on 'Oncology, understanding the latest advances

Latest advances from a global perspective like novel immunotherapies, newer Biomarkers for early detection, screening modalities and more were discussed, which were of immense benefit for practicing oncologists in India for betterment of their patients'


Lambda had organized a symposium dedicated to oncology titled 'Oncology - New Horizons' as a part of its Corporate social responsibility. It was an event built around knowledge sharing and understanding the latest advances and newer modalities of treatments amidst some of the leading cancer treatment centers and top oncologists/clinicians across the world.

Oncology was the focus point of the symposium as it is one of the leading maladies across the world and in India in particular. Its occurrence is growing year on year globally and, hence there is a dire need to have a focused approach in treatment modalities and continuous research to make therapy affordable, especially in developing countries like India.

Envisioned by their managing director, Mrs Bindi Chudgar, the two-day long symposium, scheduled in February 2014 and was hosted at Lambda's state-of-the-art facilities in Ahmedabad. The symposium witnessed a strong international participation from guest speakers from the USA and UK, eminent oncologists from well-known centers across India, and of course senior scientists from the Indian pharmaceutical industry. Inaugurated by Mr DG Shah- secretary general, IPA and Dr Pankaj Shah, well-known hematologist and ex-director GCRI, there was a valuable sharing experience.

Among the many distinguished speakers were Padmashri Dr Ashok Vaid, chairman Oncology from Medanta Cancer Institute who spoke on 'Management approach in Lung Cancer', Dr Mahesh Desai, medical director from MPUH, Nadiad who elaborated on 'Partial Nephrectomy in Kidney Tumours', Dr Vamsidhar Velcheti from Cleaveland Clinic, US and Dr Karthik Ramasamy from Oxford University, UK who gave a different and additional view of their experiences in the US and UK in treating the most difficult malady of the world.


Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box


GST: Boon or Bane for Healthcare?

Send this article by email